Table 2

Distribution of HPV genotypes found in the study according to the pathological diagnosis
Genotype found Total lesions LASIL HASIL
N % * CI95% % ** CI95% N % * CI95% % ** CI95% N % * CI95% % ** CI95%
HR-HPVs
16 23 10.3 6.6-15.1 37.1 25.2-50.3 12 8.5 4.5-14.4 30.0 16.6-46.5 10 12.7 6.2-22.0 50.0 27.2-72.8
18 2 0.9 0.1-3.2 3.2 0.4-11.2 0 0.0 0.0-2.6 0.0 0.0-8.8 2 2.5 0.3-8.8 10.0 1.2-31.7
31 13 5.8 3.1-9.8 21.0 11.7-33.2 7 5.0 2.0-10.0 17.5 7.3-32.8 6 7.6 2.8-15.8 30.0 11.9-54.3
33 6 2.7 1.0-5.8 9.7 3.6-19.9 2 1.4 0.2-5.0 5.0 0.6-16.9 4 5.1 1.4-12.5 20.0 5.7-43.7
35 5 2.2 0.7-5.2 8.1 2.7-17.8 3 2.1 0.4-6.1 7.5 1.6-20.4 2 2.5 0.3-8.8 10.0 1.2-31.7
39 5 2.2 0.7-5.2 8.1 2.7-17.8 4 2.8 0.8-7.1 10.0 2.8-23.7 1 1.3 0.0-6.9 5.0 0.1-24.9
45 8 3.6 1.6-6.9 12.9 5.7-23.9 6 4.3 1.6-9.0 15.0 5.7-29.8 2 2.5 0.3-8.8 10.0 1.2-31.7
51 14 6.3 3.5-10.3 22.6 12.9-35.0 10 7.1 3.5-12.7 25.0 12.7-41.2 4 5.1 1.4-12.5 20.0 5.7-43.7
52 19 8.5 5.2-13.0 30.6 19.6-43.7 13 9.2 5.0-15.3 32.5 18.6-49.1 6 7.6 2.8-15.8 30.0 11.9-54.3
56 5 2.2 0.7-5.1 8.1 2.7-17.8 4 2.8 0.8-7.1 10.0 2.8-23.7 1 1.3 0.0-6.9 5.0 0.1-24.9
58 13 5.8 3.1-9.8 21.0 11.7-33.2 6 4.3 1.6-9.0 15.0 5.7-29.8 7 8.9 3.6-17.4 35.0 15.4-59.2
59 7 3.1 1.3-6.4 11.3 4.7-21.9 3 2.1 0.4-6.1 7.5 1.6-20.4 4 5.1 1.4-12.5 20.0 5.7-43.7
73 5 2.2 0.7-5.1 8.1 2.7-17.8 4 2.8 0.8-7.1 10.0 2.8-23.7 1 1.3 0.0-6.9 5.0 0.1-24.9
81 5 2.2 0.7-5.1 8.1 2.7-17.8 3 2.1 0.4-6.1 7.5 1.6-20.4 1 1.3 0.0-6.9 5.0 0.1-24.9
82 1 0.4 0.0-2.5 1.6 0.0-8.7 0 0.0 0.0-2.6 0.0 0.0-8.8 1 1.3 0.0-6.9 5.0 0.1-24.9
PHR/HR-HPVs
66/68 6 2.7 1.0-5.8 9.7 3.6-19.9 5 3.5 1.2-8.1 12.5 4.2-26.8 1 1.3 0.0-6.9 5.0 0.1-24.9
PHR-HPVs
53 6 2.7 1.0-5.8 9.7 3.6-19.9 4 2.8 0.8-7.1 10.0 2.8-23.7 2 2.5 0.3-8.8 10.0 1.2-31.7
LR/PHR-HPVs
84/26 2 0.9 0.1-3.2 3.2 0.4-11.2 1 0.7 0.0-3.9 2.5 0.1-13.2 1 1.3 0.0-6.9 5.0 0.1-24.9
LR-HPVs
6 15 6.7 3.8-10.8 24.2 14.2-36.7 8 5.7 2.5-10.9 20.0 9.1-35.6 6 7.6 2.8-15.8 30.0 11.9-54.3
11 12 5.4 2.8-9.2 19.4 10.4-31.4 9 6.4 3.0-11.8 22.5 10.8-38.5 3 3.8 0.8-10.7 15.0 3.2-37.9
42 5 2.2 0.7-5.1 8.1 2.7-17.8 3 2.1 0.4-6.1 7.5 1.6-20.4 2 2.5 0.3-8.8 10.0 1.2-31.7
70 7 3.1 1.3-6.4 11.3 4.7-21.9 5 3.5 1.2-8.1 12.5 4.2-26.8 2 2.5 0.3-8.8 10.0 1.2-31.7
72 6 2.7 1.0-5.8 9.7 3.6-19.9 4 2.8 0.8-7.1 10.0 2.8-23.7 2 2.5 0.3-8.8 10.0 1.2-31.7
40/61 8 3.6 1.6-6.9 12.9 5.7-23.9 7 5.0 2.0-10.0 17.5 7.3-32.8 1 1.3 0.0-6.9 5.0 0.1-24.9
43/44 17 7.6 4.5-11.9 27.4 16.9-40.2 11 7.8 4.0-13.5 27.5 14.6-43.9 6 7.6 2.8-15.8 30.0 11.9-54.3
54/55 5 2.2 0.7-5.1 8.1 2.7-17.8 4 2.8 0.8-7.1 10.0 2.8-23.7 1 1.3 0.0-6.9 5.0 0.1-24.9
57/71 1 0.4 0.0-2.5 1.6 0.0-8.7 1 0.7 0.0-3.9 2.5 0.1-13.2 0 0.0 0.0-4.6 0.0 0.0-16.8
X 2 0.9 0.1-3.2 3.2 0.4-11.2 2 1.4 0.2-5.0 5.0 0.6-16.9 0 0.0 0.0-4.6 0.0 0.0-16.8

N: total number of times, which each genotype, was detected.

* Percentages referred to the total number of virus detected (223 viruses in the Total of lesions, 141 in the LASIL and 79 in HASIL).

** Percentages referred to the number of lesions infected by one or several genotypes (62 Total lesions, 40 LASIL and 20 HASIL).

CI95%: 95% confidence intervals used for estimate percentages.

García-Espinosa et al.

García-Espinosa et al. Diagnostic Pathology 2013 8:204   doi:10.1186/1746-1596-8-204

Open Data